May 25, 2023CorporateTerumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy ManufacturersTerumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia® Apheresis System at major conferences
May 15, 2023CorporateTerumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands
May 17, 2023 Q&A regarding Financial Results for FYE 3/2023 May 16, 2023 Audio webcast regarding Financial Results for FYE 3/2023 May 15, 2023 Presentation regarding Financial Results for FYE 3/2023 March 31, 2023 Published a new special content "From Devices to Solutions" February 13, 2023 Q&A regarding Financial Results for the Third Quarter of FYE 3/2023 February 13, 2023 Audio webcast regarding Financial Results for the Third Quarter of FYE 3/2023 February 09, 2023 Presentation regarding Financial Results for the Third Quarter of FYE 3/2023 November 14, 2022 Q&A regarding Financial Results for the First Half of FYE 3/2023 November 11, 2022 Audio webcast regarding Financial Results for the First Half of FYE 3/2023 November 10, 2022 Presentation regarding Financial Results for the First Half of FYE 3/2023 August 12, 2022 Q&A regarding Financial Results for the First Quarter of FYE 3/2023 August 10, 2022 Audio webcast regarding Financial Results for the First Quarter of FYE 3/2023 August 09, 2022 Presentation regarding Financial Results for the First Quarter of FYE 3/2023 May 31, 2022 Published a new story on "Stories - Our Technologies" May 16, 2022 Q&A regarding Financial Results for FYE 3/2022 May 13, 2022 Audio webcast regarding Financial Results for FYE 3/2022 May 12, 2022 Presentation regarding Financial Results for FYE 3/2022 Pagination Previous page ‹ Current page1 Next page ›
Top
Top